Charles Swanton
Researcher Next ID · RN-022009
Researcher · Biochemistry, Genetics and Molecular Biology
London, United Kingdom
- Works count
- 1,238
- Citation count
- 112,733
- H-index
- 142
- i10-index
- 433
Research interests
Publications
Embracing cancer complexity: Hallmarks of systemic disease
Cell · 2024 · https://doi.org/10.1016/j.cell.2024.02.009
Cancer biomarkers: Emerging trends and clinical implications for personalized treatment
Cell · 2024 · 10.1016/j.cell.2024.02.041
Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer
Journal of Thoracic Oncology · 2021 · https://doi.org/10.1016/j.jtho.2021.06.017
Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes
Cell · 2021 · https://doi.org/10.1016/j.cell.2021.03.009
Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set
Annals of Oncology · 2021 · 10.1016/j.annonc.2021.05.806
Meta-analysis of tumor- and T cell-intrinsic mechanisms of sensitization to checkpoint inhibition
Cell · 2021 · https://doi.org/10.1016/j.cell.2021.01.002
Preexisting and de novo humoral immunity to SARS-CoV-2 in humans
Science · 2020 · 10.1126/science.abe1107
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA
Annals of Oncology · 2020 · https://doi.org/10.1016/j.annonc.2020.02.011
Artificial intelligence in cancer imaging: Clinical challenges and applications
CA A Cancer Journal for Clinicians · 2019 · 10.3322/caac.21552
Neoantigen-directed immune escape in lung cancer evolution
Nature · 2019 · 10.1038/s41586-019-1032-7
Chromosomal instability drives metastasis through a cytosolic DNA response
Nature · 2018 · 10.1038/nature25432
Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic
Annals of Oncology · 2018 · https://doi.org/10.1093/annonc/mdy495
Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer
Cancer Cell · 2018 · 10.1016/j.ccell.2018.03.018
Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future
Cell · 2017 · https://doi.org/10.1016/j.cell.2017.01.018
Renal cell carcinoma
Nature Reviews Disease Primers · 2017 · https://doi.org/10.1038/nrdp.2017.9
Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution
Cell · 2017 · 10.1016/j.cell.2017.10.001
Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution
Cell · 2017 · 10.1016/j.cell.2017.10.001
Tracking the Evolution of Non–Small-Cell Lung Cancer
New England Journal of Medicine · 2017 · 10.1056/nejmoa1616288
Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis
The Lancet Oncology · 2017 · 10.1016/s1470-2045(17)30516-8
deconstructSigs: delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolution
Genome biology · 2016 · 10.1186/s13059-016-0893-4
Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
Science · 2016 · https://doi.org/10.1126/science.aaf1490
Toward understanding and exploiting tumor heterogeneity
Nature Medicine · 2015 · 10.1038/nm.3915
Biological and Therapeutic Impact of Intratumor Heterogeneity in Cancer Evolution
Cancer Cell · 2015 · 10.1016/j.ccell.2014.12.001
Spatial and temporal diversity in genomic instability processes defines lung cancer evolution
Science · 2014 · 10.1126/science.1253462
Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing
Nature Genetics · 2014 · 10.1038/ng.2891
The causes and consequences of genetic heterogeneity in cancer evolution
Nature · 2013 · 10.1038/nature12625
Replication stress links structural and numerical cancer chromosomal instability
Nature · 2013 · 10.1038/nature11935
Cancer heterogeneity: implications for targeted therapeutics
British Journal of Cancer · 2013 · 10.1038/bjc.2012.581
Intratumor Heterogeneity: Evolution through Space and Time
Cancer Research · 2012 · 10.1158/0008-5472.can-12-2217
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
New England Journal of Medicine · 2012 · https://doi.org/10.1056/nejmoa1113205
Current projects
No projects listed.